Supplementary Figures S1-6 from Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer

Autor: Tyler J. Curiel, David Henkes, Zhen-Ju Shu, Carolina B. Livi, Z. Dave Sharp, Karen Wheeler, Martin Javors, Joel E. Michalek, Marlo Nicolas, Vincent Hurez, Aashish Kabra, Neelam Z. Mukherjee, Essel de Leon, Niannian Ji, Robert S. Svatek

Supplementary Figures S1-6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96bd72f0815a33aab64dfeb2b235864
https://doi.org/10.1158/2326-6066.22539562

Data from Rapamycin Prevents Surgery-Induced Immune Dysfunction in Patients with Bladder Cancer

Autor: Tyler J. Curiel, David Henkes, Zhen-Ju Shu, Carolina B. Livi, Z. Dave Sharp, Karen Wheeler, Martin Javors, Joel E. Michalek, Marlo Nicolas, Vincent Hurez, Aashish Kabra, Neelam Z. Mukherjee, Essel de Leon, Niannian Ji, Robert S. Svatek

The mechanistic target of rapamycin (mTOR) integrates environmental inputs to regulate cellular growth and metabolism in tumors. However, mTOR also regulates T-cell differentiation and activation, rendering applications of mTOR inhibitors toward trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::781eb1e1d2df5355db10f17a1c41dae9
https://doi.org/10.1158/2326-6066.c.6549124.v1

Validation of 3D volumetric-based renal function prediction calculator for nephron sparing surgery

Autor: Jonathan A. Coleman, Aashish Kabra, Hugh White, Stephanie Nougaret, Jaime Landman, Renato B. Corradi, Melissa Suarez, Hebert Alberto Vargas, Michael A. Liss, Jacob Oppenheimer, Zhamshid Okhunov

Publikováno v: International Urology and Nephrology
International Urology and Nephrology, Springer Verlag, 2017, 49 (4), pp.615-621. ⟨10.1007/s11255-017-1525-y⟩

International audience; OBJECTIVE:To evaluate a recently published volume-based renal function prediction calculator intended to be used in small renal mass surgical counseling.METHODS:Retrospective data collection included three-dimensional calculat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c804ab245b0740b11b95312e3a6f02
https://doi.org/10.1007/s11255-017-1525-y

Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial

Autor: Kevan Iffrig, Michael A. Liss, Osamah Al-Bayati, Aashish Kabra, Jonathan Gelfond, Dharam Kaushik

Publikováno v: Urologic oncology. 36(7)

Identify modifiable factors contributing to renal cell carcinoma in the PCLO to target disease prevention and reduce health care costs.The prostate, lung, colorectal, and ovarian database were queried for the primary outcome of kidney cancer. Demogra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d279fbfd437c8e3cc782dac8c35bd61
https://pubmed.ncbi.nlm.nih.gov/29779672

Rapamycin prevents surgery-induced T cell exhaustion in patients with bladder cancer

Autor: Robert S. Svatek, Niannian Ji, Neelam Mukherjee, Essel de Leon, Aashish Kabra, Vincent Hurez, Marlo Nicolas, Joel E. Michalek, Martin Javors, Carolina Livi, Z. Dave Sharp, Tyler J. Curiel

Publikováno v: The Journal of Immunology. 200:177.8-177.8

The mechanistic target of rapamycin (mTOR) integrates environmental inputs to regulate cellular growth and metabolism in tumors. However, mTOR also regulates T cell differentiation and activation, rendering applications of mTOR inhibitors towards tre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7c22b6206aef9d8091af84d18eb10314
https://doi.org/10.4049/jimmunol.200.supp.177.8